Drugs / FID 123320 Ophthalmic Solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06538662 | Oct 2024 → Jan 2025 | ocular hyperemia | Alcon Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FID 123320 Ophthalmic Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06538662 ↗ |
| Route | Other | “1 drop instilled in each eye at Visit 2 (Day 1), followed by one drop instilled in each eye twice a day (approximately 12 hours apart) Day 2 up to Visit 5 (Day 56), followed by...” NCT06538662 ↗ |